Alps Advisors Inc Madrigal Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$72.34 - $95.09 $1.47 Million - $1.93 Million	-20,338 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$78.35 - $105.02 $110,160 - $147,658	-1,406 Reduced 6.47%	20,338 $1.62 Million
Q2 2021 Aug 11, 2021	SELL	$97.2 - $137.59 $606,042 - $857,873	-6,235 Reduced 22.28%	21,744 $2.12 Million
Q1 2021 May 07, 2021	BUY	$108.54 - $125.2 $8,140 - $9,390	75 Added 0.27%	27,979 $3.27 Million
Q4 2020 Feb 03, 2021	BUY	$110.06 - $133.7 $904,913 - $1.1 Million	8,222 Added 41.77%	27,904 $3.1 Million
Q3 2020 Nov 04, 2020	SELL	$99.78 - $124.21 $136,199 - $169,546	-1,365 Reduced 6.49%	19,682 $2.34 Million
Q2 2020 Aug 05, 2020	SELL	$60.13 - $125.71 $421,270 - $880,724	-7,006 Reduced 24.97%	21,047 $2.38 Million
Q1 2020 May 06, 2020	SELL	$66.76 - $93.49 $198,076 - $277,384	-2,967 Reduced 9.56%	28,053 $1.87 Million
Q4 2019 Feb 07, 2020	BUY	$84.28 - $118.5 $22,165 - $31,165	263 Added 0.86%	31,020 $2.83 Million
Q3 2019 Nov 04, 2019	SELL	$84.4 - $106.53 $127,950 - $161,499	-1,516 Reduced 4.7%	30,757 $2.65 Million
Q2 2019 Aug 07, 2019	SELL	$91.13 - $142.5 $447,174 - $699,247	-4,907 Reduced 13.2%	32,273 $3.38 Million
Q1 2019 May 01, 2019	BUY	$103.48 - $143.84 $166,395 - $231,294	1,608 Added 4.52%	37,180 $4.66 Million
Q4 2018 Feb 04, 2019	BUY	$94.77 - $215.54 $793,983 - $1.81 Million	8,378 Added 30.81%	35,572 $4.01 Million
Q3 2018 Oct 25, 2018	BUY	$207.3 - $300.31 $1.37 Million - $1.99 Million	6,615 Added 32.14%	27,194 $5.82 Million
Q2 2018 Aug 02, 2018	BUY	$101.55 - $313.9 $683,634 - $2.11 Million	6,732 Added 48.62%	20,579 $5.76 Million
Q2 2018 Jul 25, 2018	SELL	$101.55 - $313.9 $500,844 - $1.55 Million	-4,932 Reduced 26.26%	13,847 $1.27 Million
Q1 2018 May 01, 2018	BUY	$93.35 - $149.04 $460,402 - $735,065	4,932 Added 35.62%	18,779 $2.19 Million
Q4 2017 Feb 05, 2018	BUY	$39.35 - $97.37 $544,879 - $1.35 Million	13,847	13,847 $1.27 Million

Others Institutions Holding MDGL

# of Institutions

296

Shares Held

22M

Call Options Held

819K

Put Options Held

640K

Janus Henderson Group PLC London, X0

2.48M
Shares

$861 Million
0.28% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

2.04M
Shares

$709 Million
29.57% of portfolio
Avoro Capital Advisors LLC New York, NY

2.03M
Shares

$705 Million
6.48% of portfolio
Rtw Investments, LP New York, NY

1.99M
Shares

$693 Million
6.74% of portfolio
Baker Bros. Advisors LP New York, NY

1.97M
Shares

$686 Million
4.49% of portfolio

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account